Declining HIV infection rates among recently married primigravid women in Pune, India. 2007

Nikhil Gupte, and Jayagowri Sastry, and Ronald Brookmeyer, and Mrudula A Phadke, and Ramesh A Bhosale, and Robert C Bollinger, and , and
BJ Medical College (BJMC)-Johns Hopkins University (JHU), School of Medicine and Bloomberg School of Public Health Mother-to-Child Transmission (MTCT) Clinical Trial Unit, Pune, India.

BACKGROUND A single recent study has suggested a decrease in HIV risk for women attending antenatal clinics (ANCs) in southern India. Yet, some have questioned the validity of the Indian national surveillance data and analyses. Previous studies suggest that the only major HIV risk factor for married Indian women is the risk behavior of their husbands. Therefore, to address concerns about potential selection bias in the analysis of sentinel surveillance data from multiple sites, we estimated the trajectory of HIV transmission rates among recently married, monogamous, primigravid women attending a single large ANC in Pune, India. METHODS Participants were self-referred, young, primigravid women from 18 to 27 years of age consenting to HIV screening. Time trends in HIV prevalence over 3.5 years were evaluated by logistic regression adjusted for age. HIV incidence was estimated by dividing the number of HIV-infected mothers by an estimate of exposure person-time, which was an estimate of the average age-specific duration of marriage. RESULTS Between August 16, 2002 and February 28, 2006, 30,085 (79.5%) of 37,858 pregnant women consented to HIV screening; 10,982 (36.5%) were primigravid and their age range was from 18 to 27 years. HIV infection risk declined over 3.5 years among primigravid women. An estimated 19,739 person-years (PYs) of exposure yielded an overall HIV incidence rate 1.25/100 PYs (95% confidence interval [CI]: 1.10 to 1.42). Estimated HIV incidence decreased from 2.2/100 PYs (95% CI: 1.6 to 3.0) in 2002 to 2003 to 0.73/100 PYs (95% CI: 0.5 to 1.0) in 2006. CONCLUSIONS HIV infection risk among young primigravid women in Pune seems to have decreased over the past 3.5 years. A decreasing HIV risk among pregnant women in Pune would also decrease the number of HIV-exposed infants. We hypothesize that decreased high-risk sexual behavior among young recently married men is most likely contributing to a decreasing risk to their wives and children in Pune.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D005260 Female Females
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Nikhil Gupte, and Jayagowri Sastry, and Ronald Brookmeyer, and Mrudula A Phadke, and Ramesh A Bhosale, and Robert C Bollinger, and , and
June 2011, Transactions of the Royal Society of Tropical Medicine and Hygiene,
Nikhil Gupte, and Jayagowri Sastry, and Ronald Brookmeyer, and Mrudula A Phadke, and Ramesh A Bhosale, and Robert C Bollinger, and , and
January 2018, PloS one,
Nikhil Gupte, and Jayagowri Sastry, and Ronald Brookmeyer, and Mrudula A Phadke, and Ramesh A Bhosale, and Robert C Bollinger, and , and
August 2007, Journal of acquired immune deficiency syndromes (1999),
Nikhil Gupte, and Jayagowri Sastry, and Ronald Brookmeyer, and Mrudula A Phadke, and Ramesh A Bhosale, and Robert C Bollinger, and , and
March 2006, Journal of acquired immune deficiency syndromes (1999),
Nikhil Gupte, and Jayagowri Sastry, and Ronald Brookmeyer, and Mrudula A Phadke, and Ramesh A Bhosale, and Robert C Bollinger, and , and
January 2018, PloS one,
Nikhil Gupte, and Jayagowri Sastry, and Ronald Brookmeyer, and Mrudula A Phadke, and Ramesh A Bhosale, and Robert C Bollinger, and , and
October 2008, AIDS care,
Nikhil Gupte, and Jayagowri Sastry, and Ronald Brookmeyer, and Mrudula A Phadke, and Ramesh A Bhosale, and Robert C Bollinger, and , and
December 1997, JAMA,
Nikhil Gupte, and Jayagowri Sastry, and Ronald Brookmeyer, and Mrudula A Phadke, and Ramesh A Bhosale, and Robert C Bollinger, and , and
March 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Nikhil Gupte, and Jayagowri Sastry, and Ronald Brookmeyer, and Mrudula A Phadke, and Ramesh A Bhosale, and Robert C Bollinger, and , and
July 2007, AIDS care,
Nikhil Gupte, and Jayagowri Sastry, and Ronald Brookmeyer, and Mrudula A Phadke, and Ramesh A Bhosale, and Robert C Bollinger, and , and
January 2006, Journal of acquired immune deficiency syndromes (1999),
Copied contents to your clipboard!